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Phylogenetic and phenotypic analysismic dengue viruses (DENV) circulate between humans and peridomestic Aedes
mosquitoes. At present endemic DENV infect 100 million people per year, and a third of the global population
is at risk. In contrast, sylvatic DENV strains are maintained in a transmission cycle between nonhuman
primates and sylvatic Aedes species, and are evolutionarily and ecologically distinct from endemic DENV
strains. Phylogenetic analyses place sylvatic strains basal to each of the endemic serotypes, supporting the
hypothesis that each of the endemic DENV serotypes emerged independently from sylvatic ancestors. We
utilized complete genome analyses of both sylvatic and endemic DENV serotype 2 (DENV-2) to expand our
understanding of their genetic relationships. A high degree of conservation was observed in both the 5′- and
3′-untranslated genome regions, whereas considerable differences at the nucleotide and amino acid levels
were observed within the open reading frame. Additionally, replication of the two genotypes was compared
in cultured cells, where endemic DENV strains produced a signiﬁcantly higher output of progeny in human
liver cells, but not in monkey kidney or mosquito cells. Understanding the genetic relationships and
phenotypic differences between endemic and sylvatic DENV genotypes may provide valuable insight into
DENV emergence and guide monitoring of future outbreaks.
© 2008 Elsevier Inc. All rights reserved.Introduction
The natural history of dengue viruses (DENV, genus Flavivirus, family
Flaviviridae) encompasses two ecologically and evolutionarily distinct
transmission cycles: sylvatic (forest) enzootic maintenance cycles
probably involve transmission among nonhuman primates by arboreal
mosquitoes of the genus Aedes, whereas endemic/epidemic cycles
(henceforth called endemic) involve human reservoir and ampliﬁcation
hosts and peridomestic Aedes spp. vectors, primarily Ae. aegypti and Ae.
albopictus (Gubler, 1998). The four serotypes of endemic DENV (DENV-
1–4) are the etiologic agents of several forms of dengue disease, a cause
of severe morbidity and mortality among urban and peri-urban
populations in the tropics and neotropics worldwide. By current
estimates, 100 million infections of dengue fever (DF) occur annually,
including up to 500,000 cases of the more severe form of disease called
dengue hemorrhagic fever (DHF) with a case fatality rate of up to 5%
(Halstead, 1997). While the biology of endemic DENV has been studied
extensively (Halstead et al., 1973a,b,c; 1977; Halstead and O'Rourke,du (S.C. Weaver).
rsity of Pittsburgh, Pittsburgh,
l rights reserved.1977;Halstead andPalumbo,1973;Kuberski et al.,1977;Marchette et al.,
1973; Rosen, 1958; Rosen and Gubler, 1974; Sabin, 1952; Scherer et al.,
1978), much less is known about the sylvatic strains.
DENV sylvatic cycles have been demonstrated in Asia, where
serologic evidence as well as virus isolation indicate transmission of
sylvatic strains of DENV-1, -2, and -4 amongMacaca and Presbytis spp.
monkeys, vectored by Ae. niveus mosquitoes (Peiris et al., 1993;
Rudnick and Lim, 1986). In West Africa, DENV-2 is the only sylvatic
serotype known to circulate, between Erythrocebus patas and possibly
other monkeys and various sylvatic Aedes sp., including Ae. taylori, Ae.
furcifer, Ae. vitattus, and Ae. luteocephalus, in a sylvatic focus in the
vicinity of Kedougou, Senegal (Diallo et al., 2003, 2005; Rodhain,1991;
Saluzzo et al., 1986b) as well as in other nearby nations.
Phylogenetic analyses of DENV based on envelope protein (E) gene
nucleotide (nt) sequences representing strains from diverse localities
around the world consistently place each sylvatic DENV serotype
(DENV-1, -2 and -4) basal in relation to the corresponding endemic
DENV serotype (Chang et al., 1994; Rico-Hesse, 1990; Twiddy et al.,
2002a; Wang et al., 2000), consistent with an ancestral status of the
sylvatic lineages and independent emergence of the endemic lineages
from sylvatic ancestors. Furthermore, DENV-2 are grouped into ﬁve
genotypes (Shurtleff et al., 2001; Twiddy et al., 2002a) based on the
phylogenetic relationships of the E gene nucleotide sequences (Chang
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adaptation of DENV-2 to distinct geographic and host–vector niches is
reﬂected by the differences in incidence and virulence exhibited by
these DENV-2 genotypes (Shurtleff et al., 2001). While initial evidence
suggested that emergence of sylvatic DENV-2 into the endemic cycle
was likely facilitated by adaptation to replicate more efﬁciently in the
peridomestic mosquito vectors Ae. aegypti and Ae. albopictus (Mon-
cayo et al., 2004), more extensive studies have indicated that this
adaptation pertains only to the Asian genotype of endemic DENV-2
(Cologna et al., 2005). Moreover, comparison of the replication of
sylvatic and endemic DENV-2 in models for human infection indicate
that emergence of endemic DENV-2 from sylvatic progenitors may not
have required adaptation to replicate more efﬁciently in humans
(Vasilakis et al., 2007b).
Although limited spillover transmission of sylvatic DENV-2 to
humans has been documented in West Africa (Saluzzo et al., 1986a;
Zeller et al., 1992), there is no evidence that these sylvatic DENV are
involved in secondary ampliﬁcations in humans, perhaps due to their
conﬁnement to forest habitats and lack of contact with the
peridomestic DENV vectors (Diallo et al., 2003). However, recent
reports have shown that the gallery forest-dwelling mosquito Ae.
furcifer is highly susceptible to sylvatic DENV infection (Diallo et al.,
2005) and shows a pattern of movement into peridomestic habitats
(villages) in eastern Senegal (Diallo et al., 2003), suggesting that this
species may act as a bridge vector for exchange between forest and
peridomestic habitats. Furthermore, recent phylogenetic analyses
based on complete DENV-2 genomes from human isolates associated
with a 1966 outbreak of dengue fever in Nigeria suggest limited
spillover outbreaks of sylvatic DENV (deﬁned as the enzootic
transmission into a small, localized group of people often conﬁned
to a village or a small area due to favorable ecological conditions, such
as increased vector densities) (Carey et al., 1971; Vasilakis et al., 2008).
Collectively, these data imply a high potential for sylvatic DENV-2
emergence into the endemic cycle.
Previous analyses of endemic DENV-2 based on full genomic
sequences (Leitmeyer et al., 1999; Twiddy et al., 2002b) or of endemic
and sylvatic DENV-2 based on envelope gene sequences (Wang et al.,
2000) or complete sequences (Vasilakis et al., 2007a) identiﬁedTable 1
Passage history of DENV-2 strains
Virus strain Epidemiological typea Host Passage historyb
16681c Endemic Human BSC-1 –X, MK2 – 6, Rh.
C6/36 – 4, MK2 – 1, C6
1349c Endemic Human SM – 2, C6/36 – 2
IQT-1950 Endemic Human C6/36 – 2
1328 Endemic Human Mosq - 2, C6/36 – 1
TVP1915c Endemic Ae. aegypti SM – 4, C6/36 – 1
PM33974 Sylvatic Ae. africanus Tx.amboinensis 1, C6/36
DakAr 578 Sylvatic Ae. taylori SM – 8, C6/36 – 1
DakAr 510c Sylvatic Ae. taylori SM – 4, C6/36 – 1
DakAr 2039 Sylvatic Ae. luteocephalus SM – 6, C6/36 – 1
DakAr A1247 Sylvatic Ae. taylori SM – 5, C6/36 – 1
DakAr HD10674c Sylvatic Human SM – 25, mosq – 1
DakAr D20761 Sylvatic Ae. luteocephalus SM – 8, C6/36 – 1
DakAr A2022 Sylvatic Ae. africanus SM – 6, C6/36 – 1
DakAr D75505c Sylvatic Ae. luteocephalus AP61 – 5, C6/36 – 1
DakAr 141069 Sylvatic Ae. luteocephalus AP61 – 1, C6/36 – 1
DakAr 141070 Sylvatic Ae. luteocephalus AP61 – 5, C6/36 – 1
IBH11208c Sylvatic Human SM – 30, C6/36 – 1
IBH11234c Sylvatic Human SM – 16, C6/36 – 1
IBH11664 Sylvatic Human SM – 5, C6/36 – 1
P8-1407c Sylvatic Sentinel Monkey SM – 3, C6/36 – 2
DENV isolates obtained from the UTMBWorld Reference Center for Emerging Viruses and Ar
for further evaluation.
a Endemic denotes human or Ae. aegypti isolates or strains that are associated with perid
b SM— suckling mouse; C6/36 — Ae. albopictus cell line; MK2— Rhesus monkey kidney ce
N/A — Not available.
c Virus strains selected for phenotypic characterization.various mutations that were hypothesized to play a role in DENV
Darwinian evolution and pathogenesis. We sought to expand our
understanding of the phylogenetic relationships between sylvatic and
endemic DENV-2 by performing analyses of full genomic sequences,
focusing mainly on isolates of mostly low passage histories. Moreover,
we analyzed the distribution of speciﬁc mutations that are likely to
contribute to phenotypic differences. We included in this study 25
endemic DENV-2 complete genomic sequences from GenBank that
represent the full genotypic diversity of this serotype. We also
included the complete genome sequences of 15 West African and
one Southeast Asian DENV-2 sylvatic isolates (Table 1) utilized in our
recent studies (Vasilakis et al., in press, a; 2008). To better link genetic
and phenotypic variation, we alsomeasured the replication of a subset
of endemic and sylvatic isolates, including sylvatic strains isolated
from humans, in both mammalian and mosquito cells in culture.
Results and discussion
Phylogenetic analyses
Phylogenetic analyses of 40 DENV-2 isolates (25 endemic and 15
sylvatic representing strains from diverse localities throughout the
tropics and neotropics were performed based on complete genome
sequences. The isolates selected for this study are representative
members of all previously-deﬁned major genotypes (Holmes and
Twiddy, 2003; Twiddy et al., 2002a; Wang et al., 2000), and as
expected they clustered into six distinct clades in this study as well
(Fig. 1). Consensus trees based on Maximum-likelihood (ML) or
Bayesian analyses exhibited identical strain topologies and only
minor differences in bootstrap values and thus we present only
Bayesian phylogenies. Sylvatic DENV-1 and -4, as well as endemic
DENV-1 and -3 were used as outgroups to root the tree (Fig. 1).
Considerable genetic diversity was apparent within each of the
major DENV-2 genotypes, reﬂecting a continual process of diver-
gence within each lineage. All sylvatic DENV-2 strains were distinct
from and basal to the endemic clade, and the Malaysian and West
African sylvatic DENV-2 strains were genetically distinct. All
analyses also delineated a chronological divide among isolatesLocation Year GenBank accession no.
Macaque – 1, Tx.amboinensis – 2,
/36 – 1
Thailand 1964 U87411
Burkina Faso 1982 EU056810
Peru 1995 EU056811
Puerto Rico 1977 EU056812
Burkina Faso 1986 N/A
– 2 Guinea 1981 EF105378
Cote d'Ivoire 1980 EF105380
Cote d'Ivoire 1980 EF105381
Burkina Faso 1980 EF105382
Cote d'Ivoire 1980 EF105383
Senegal 1970 EF105384
Senegal 1974 EF105385
Burkina Faso 1980 EF105386
Senegal 1991 EF457904
Senegal 1999 EF105389
Senegal 1999 EF105390
Nigeria 1966 EF105387
Nigeria 1966 EU003591
Nigeria 1966 EF105388
Malaysia 1970 EF105379
boviruses and ampliﬁed once on C6/36 mosquito cells to achieve sufﬁciently high titers
omestic transmission.
lls; BSC-1— African green monkey kidney cells; AP61 — Aedes pseudoscutellaris cell line;
Fig. 1. Phylogenetic analysis of sylvatic DENV-2 isolates. Phylogenetic tree derived from complete genome nucleotide sequences of sylvatic and representative endemic DENV-2 strains
using Bayesian analysis. Genomic sequences from sylvatic dengue serotypes 1 (strain P72-1244) and 4 (strain P75-215), as well as endemic serotype 1 (strain FGA) and 3 (strain H87) were
used as outgroups to root the DENV-2 tree. Numbers indicate bootstrap values for monophyletic groups to the right. Asterisks indicate DENV strains used to evaluate growth kinetics.
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formed a group distinct from all post-1980 isolates. This observation
supports recent evidence of rapid sylvatic DENV turnover (rapid
generation of viral diversity) due to their high nucleotide substitu-
tion rates (Vasilakis et al., 2007a).
The endemic DENV-2 phylogeny also showed a subdivision
between the American and Asian genotypes. Within the Asian
genotype, two further sub-lineages represented the cosmopolitan
and the Asian clades, with bootstrap support of 100%. The former
included isolates that are geographically dispersed throughout the
tropics (Twiddy et al., 2002a), whereas the latter included isolates
found exclusively in Asia (Asian) as well as recent isolates that have
been implicated with the appearance of DHF and displacement of
American genotypes in the Americas (Asian/American) (Cologna et al.,
2005) (Fig. 1).Genetic analysis
The DENV genome is a single stranded RNA approximately 10.7
kilobases (kb) long, capped and of positive polarity, comprising a
single open reading frame (ORF) ﬂanked by non-coding regions (NCR)
at both the 5′- and 3′-ends. The ORF encodes three structural proteins:
capsid (C), premembrane/membrane (prM) and envelope (E), as well
as seven nonstructural proteins, NS1, NS2A, NS2B, NS3, NS4A, NS4B
and NS5. The 5′-NCR is about 100 nucleotides long, whereas the 3′-
NCR is approximately 400 nt long.
5′- and 3′-NCRs
As demonstrated in previous studies, both 5′- and 3′-NCRs were
highly conserved (Hahn et al., 1987; Proutski et al., 1997; Rauscher
Table 3
Nucleotide identity (%) between the consensus sequence for the 5′-UTR (above the
diagonal) and 3′-UTR (below the diagonal) of the Asian, American endemic, and sylvatic
DENV-2
5′-UTR Asian American Sylvatic
Asian 100.0 96.9 92.8
American 92.7 100.0 91.8
Sylvatic 91.2 89.4 100.0
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showed high similarity within and between groups in both the 5′- and
3′-NCR sequences (Tables 2 and 3, Supplemental Table S1), as well as
predicted secondary structures (data not shown). The ﬂavivirus 3′-
NCR can be subdivided into three subregions: the Variable Region
(VR), the core, and the 3′ terminus (Markoff 2003). A number of highly
conserved sequence elements have been identiﬁed in the core and 3′
terminus, including: (i) the last two plus-strand 3′-terminal nucleo-
tides (UC-3′), which are complimentary to the 5′-terminal nucleotides
(5′AG), and play a role in the cyclization of the genome during the
early stages of replication (Markoff, 2003; Rice et al., 1985; Wengler,
1981); (ii) the pentanucleotide sequence 5′-CACAG, between nucleo-
tides 43 and 47, which form a closed loop located within the
conserved stem and loop structure (3′-SL) of the 3′-NCR terminal 95
nucleotides (Brinton et al., 1986; Hahn et al., 1987; Irie et al., 1989), and
are thought to play a signiﬁcant role during viral replication by
facilitating the binding of cellular and/or viral factors to the 3′-SL
(Blackwell and Brinton, 1995, 1997; Ta and Vrati, 2000). However,
recent evidence suggests that conservation of the pentanucleotide
sequence may not be required for replication (Silva et al., 2007); (iii)
the cyclization sequence (CYC) 5′-ATATTGAC, a fully conserved
sequence among DENV genotypes between nucleotides 97 and 102,
located within the longer semi-conserved motif CS1 (Khromykh et al.,
2001a; Markoff, 2003); and (iv) the tandem repeat sequences CS2,
RCS2, TL1 (5′-GAAGCUGUACG) and TL2 (5′-GAAGCUGUA), the former
two located approximately 20 and 90 nucleotides upstream of CS1,
whereas the latter two are located upstream of RCS2 and between
RCS2 and CS2, respectively. Several investigators have suggested that
the conserved sequences (indicated above in bold) within TL1 and TL2
could interact through hydrogen bonding with the conserved
sequences 5′-ACAGC and 5′-GCUGC (located downstream of CS2 and
between RCS2 and CS2 respectively) to form pseudoknots (Olsthoorn
and Bol, 2001; Proutski et al., 1997; Rauscher et al., 1997), possibly to
facilitate the proper folding of the 3′-NCR, thus contributing to its
proper function in ﬂavivirus replication. However, a recent study
suggested that substantial distortion of the pseudoknot secondary
structure by mutations may be tolerated without abolishing viral
replication (Romero et al., 2006).
All of these sequence features were conserved in both the endemic
and sylvatic DENV-2 strains. However, in the VR, the Asian and
American endemic genotypes exhibited 2 and 10 nt deletions,
respectively (Supplemental Table S2). It has been suggested that
these deletions were introduced during their evolution from sylvatic
progenitors (Leitmeyer et al., 1999; Shurtleff et al., 2001). MoreoverTable 2
Genetic sequence of selected dengue-2 sylvatic strains
Virusa Epidemiological type Location Genome length
PM33974 Sylvatic Guinea 10722
P8-1407 Sylvatic Malaysia 10719
DakAr510 Sylvatic Côte d' Ivoire 10722
DakAr2039 Sylvatic Burkina Faso 10722
DakAr A1247 Sylvatic Côte d' Ivoire 10700
DakAr578 Sylvatic Côte d' Ivoire 10722
DakAr HD10674 Sylvatic Senegal 10724
DakAr A2022 Sylvatic Burkina Faso 10721
DakArD20761 Sylvatic Senegal 10724
DakArD77505 Sylvatic Senegal 10724
DakAr141069 Sylvatic Senegal 10723
DakAr141070 Sylvatic Senegal 10717
IBH 11208 Sylvatic Nigeria 10709
IBH 11234 Sylvatic Nigeria 10515c
IBH 11664 Sylvatic Nigeria 10711
a Low passage DENV isolates were obtained from the UTMBWorld Reference Center for Em
sufﬁciently high titers for further evaluation.
b Denotes % identity compared to West African PM33974 sylvatic strain.
c Partial sequence.
d % nt identity was based on partial sequence comparison.sylvatic genotypes IBH11208 and IBH11664 contained a 14 nt deletion
in this region. Among other ﬂaviviruses, this regionmay act as a spacer
to protect the well-conserved and structurally important distal 3′
terminus, which exhibits similar variability (Proutski et al., 1999).
Open Reading Frame (ORF)
Multiple sequence alignment of the ORFs of the endemic and
sylvatic genotypes, and comparison of the sylvatic sequences to the
prototype Southeast Asian endemic 16681 sequence, revealed a large
number of nucleotide differences, many of which were nonsynon-
ymous (Table 4).
Structural genes
The capsid protein (C) an 11 kDa homodimer protein with an
unusually high net charge (Trent, 1977) essential for the speciﬁc RNA
genome encapsidation (Chang et al., 2001), contained 5 nonsynon-
ymous (I26V, S79N, F104M/V/I, L105I and V108L/M) differences
between all endemic versus sylvatic genotypes (Table 4). The a-helical
rich content of the capsid structure (Jones et al., 2003; Kuhn et al.,
2002; Ma et al., 2004) was fully conserved (V26-L35, K45-T58, A63-
W69 and K74-N96) within all genotypes, except for endemic-speciﬁc
differences at positions 26 (I26V) and 79 (S79N) located within the
ﬁrst and fourth a-helical domain. Similarly conserved was the
hydrophobic region 46L-66L. Whether the observed residue changes
have any effect in the assembly or processing of the CAP during the
late stages of DENV infection is not known.
The membrane protein (prM), a 27–31 kDa N-glycosylated protein
cleaved in the trans-Golgi by a resident furin-like protease during late
stage virus assembly, contained 14 nonsynonymous mutations of
which 4 [K28E, I31T (pr) and A61V and V70I (M)] were speciﬁc to
American genotypes, and one (I31V) shared among all Asian-endemic
genotypes (Table 4). Amino acid 68, the only available site for N-linked% nt identityb % aa identityb ORF (nt) 5′-NCR (nt) 3′-NCR (nt)
– – 10176 96 450
87.7% 98.6% 10176 96 447
98.8% 99.8% 10176 96 450
98.8% 99.7% 10176 96 450
98.6% 99.8% 10176 96 428
98.7% 99.8% 10176 96 450
96.7% 99.4% 10176 96 452
98.8% 99.9% 10176 95 450
96.6% 99.3% 10176 96 452
97.4% 99.6% 10176 96 452
97.3% 99.5% 10176 96 450
97.2% 99.5% 10170 96 442
96.6% 99.2% 10176 96 437
94.8%d 99.1% 10176 96 243c
96.6% 99.2% 10176 96 437
erging Viruses and Arboviruses and ampliﬁed once on C6/36 mosquito cells to achieve
able 4
ummary of consistent amino acid substitutions between sylvatic and endemic
outheast Asian, American DENV-2 genotypes
ene Sitea Typeb Amino acid substitution Comment
apsid 26 E I→V
79 E S→N
104 E F→M/V/I P8-1407 F→L
105 E L→ I
108 E V→L/M P8-1407 V→ I
rM 16 E K→R/I
17 E N→Q P8-1407 N→H
28 E-Am K→E
29 E N→D P8-1407 N→D
31 E-Am I→T
31 E-As I→V P8-1407 I→M
49 E V→ I P8-1407, IBH11208 V→ I
55 E-As F→L
57 E-As K→R
81 E S→T
82 E S→T/A P8-1407 S→T
(mature) 28 E Q→H
44 E L→ I/M
48 E V→ I P8-1407 V→ I
61 E-Am A→V/A
70 E-Am V→ I
59 E F→Y
71 E-Am E→D
81 E-Am S→T
83 E V→N/K
93 E R→K P8-1407 R→K
122 E L→K
124 E K→N P8-1407 K→N
129 E-Am V→ I
139 E-Am I→V
162 E-As V→ I
171 E A→T P8-1407 A→T
181 E I→V
236 E M→T
247 E R→K P8-1407 R→K
276 E I→L P8-1407 I→L
279 E M→T P8-1407 M→T
330 E D→G P8-1407 D→G
345 E K→R
365 E I→V
379 E V→ I P8-1407, IBH11208 V→ I
390 E-Am N→D
425 E I→L P8-1407 I→L
432 E V→ I
462 E V→ I P8-1407 V→ I
478 E T→S
S1 37 E D→E
73 E-Am P→S
92 E E→D P8-1407 E→D
99 E-Am A→V
101 E R→K P8-1407 R→K
105 E K→R
112 E-As R→K P8-1407 R→K
123 E V→M
129 E Q→H
141 E T→A
146 E S→T
162 E I→V A2022 I→F
170 E-Am R→K
177 E-As M/T→V/A
178 E I/V→F P8-1407 I/V→F
188 E V→ I
191 E D→N P8-1407 D→N
205 E R→A
212 E M→ I/M
224 E Y→H
227 E R→K
242 E-Am I→V
256 E-Am Y→N
261 E Y→H
278 E E→D
347 E-Am N→S
S2A 12 E-As I→V
18 E L→F P8-1407 L→F
33 E L→ I
Table 4 (continued)
Gene Sitea Typeb Amino acid substitution Comment
NS2A 38 E I→V
51 E K→R
57 E I→M/V
58 E I→V P8-1407 I→V
63 E A→T
67 E E→D
68 E M→ I
82 E R→K P8-1407 R→K
89 E V→A P8-1407 V→A
102 E L→M P8-1407 L→M
104 E A→T/A P8-1407 A→T
108 E V→ I
115 E-Am N→T
115 E-As N→S
118 E G→E P8-1407 G→E
120 E-Am V→ I
127 E I→L/W
131 E I→M
139 E S→N/K
149 E V→ I P8-1407 V→ I
152 E M→ I
155 E I→V
158 E V→A P8-1407 V→A
159 E M→V P8-1407 T→V
163 E H→N
168 E G→S P8-1407 G→S
174 E A→V/A IBH11208 A→V
189 E T→A
195 E V→A P8-1407, 20761, 10674 V→A
214 E P→T
215 E N→S
217 E T→K
NS2B 55 E K→R
57 E-Am A→T
58 E E→D
62 E-Am E→D
76 E V→ I
126 E T→V
NS3 13 E M→V
28 E R→K
55 E V→M P8-1407 V→M
117 E-Am K→R
140 E I→V
160 E T→A
164 E S→A
172 E V→ I P8-1407 V→M
186 E K→R
213 E R→K/N
248 E K→R
273 E-As I→V P8-1407 I→V
335 E V→M/I P8-1407 V→M
351 E I→V
353 E N→D
366 E R→K
367 E-Am A→T
381 E-As R→K
392 E T→S P8-1407 T→S
395 E I→V P8-1407 I→V
442 E V→ I P8-1407 V→ I
466 E-Am K→R
538 E K→R P8-1407 K→R
552 E S→A
561 E K→R P8-1407 K→R
568 E-Am I→T
569 E-As R→K/Q
577 E M→V
581 E V→ I
600 E T→ I
NS4A 5 E S→N
21 E T→A
33 E S→T P8-1407 S→T
36 E M→A/T P8-1407 M→T
39 E-Am R→K
59 E G→T
78 E V→ I
93 E G→ I/S
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Table 4 (continued)
Gene Sitea Typeb Amino acid substitution Comment
NS4A 138 E-Am V→ I P8-1407 V→ I
144 E L→V
NS4B 17 E-As G→S
17 E-Am G→H/N
24 E I/T→S P8-1407 I→A
155 E E→D
201 E-Am I→V
211 E K→R
241 E R→K P8-1407 R→K
245 E-As S→N
246 E A→T
NS5 3 E T→N
21 E R→K
71c E A→T
134c E-Am T→V
138c E R→K
172 E G→N
173 E S→N
179 E-As V→ I
192 E-As R→K
200 E F→Y
268 E C→S
273 E M→L
374d E R→K
382d E G→K P8-1407 G→N
386d E R→K
387d E R→K P8-1407 R→K
389d E K→T
392d E M→ I
396d E A→E
99d E C→T
400d E-Am N→K
400d E-As N→R
411 E V→ I
428 E-Am E→N/S
428 E-As E→S/G
435 E E→D
443 E D→E P8-1407 D→E
521e E I→V
523e E R→K IBH11208 R→K
525e E A→E P8-1407 A→E
NS5 543e E-Am S→ I
543e E-As S→L
552e E-As I→V
554e E D→N P8-1407 D→N
555e E Q→H
557e E-Am E→A
559e E R→E P8-1407 R→K
627e E L→ I/V
632e E L→Q P8-1407 L→Q
636e E P→A/V P8-1407 P→S
637e E-Am Q→S
637e E-As Q→T
643e E H→K/Q
644e E-Am A→D
644e E-As A→N
647e E-As V→A
649e E E→V
655e E A/T→S
675e E-Am R→K P8-1407 R→K
675e E-As R→S
697e E K→R
700e E S→N P8-1407 S→N
722e E-Am K→T
722e E-As K→V
799e E-As S→K/T P8-1407 S→T
818e E-Am Q→L
819e E D→E
834e E D→E
871e E A→S
875e E E→N/S
890e E S→R P8-1407 S→R
895e E S→A
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(Nowak andWengler, 1987), as well as the consensus sequence 87R-X-
K-R90 proximal to the cleavage site were fully conserved.
The envelope (E) protein is a 53 kDa class II N-glycosylated dimeric
membrane fusion protein that mediates virus binding and fusion to
host cell membrane (Johnson et al., 1994; Modis et al., 2004; Rey et al.,
1995), as well as confers protective immune responses by eliciting
neutralizing, antifusion, and replication-enhancing antibodies (Chen
et al., 1996; Roehrig et al., 1998). Each of the monomer subunits of the
E protein is composed of three distinct domains: the centrally located
domain I, a β-barrel structure oriented parallel to the viral membrane;
domain II, a ﬁnger-like structure composed of a pair of discontinuous
loops one of which is highly conserved among all ﬂaviviruses
functioning as an internal fusion peptide and is stabilized by three
disulﬁde bridges; and the C-terminal domain III (aa 303–395),
containing a single disulﬁde bond and located in the outer lateral
surface of the dimer. Domain III has been suggested to contain
residues that are responsible for the determination of host range,
tropism and virulence among ﬂaviviruses (Rey et al., 1995). Twelve
cysteine residues that form the six disulﬁde bridges, as well as the two
N-linked glycosylation sites (N67 and N153) (Johnson et al., 1994)
were conserved among all DENV-2 strains. There were 25 evenly
distributed, endemic-speciﬁc nonsynonymous mutations of which
ﬁve (D330G, K345R, I365V, V379I and N390D) were located within the
critical domain III (Table 4). One of these mutations (N390D), which is
shared only by the American genotypes, is located within the putative
glycosaminoglycan binding motif (386L-411M) responsible for the
binding of DENV onto the host cell membrane via a non-Fc receptor
(Chen et al., 1996). N390D has also been implicated as a potential
virulence determinant in American DENV genotypes (Leitmeyer et al.,
1999), and has been shown to alter virulence in mice (Sanchez and
Ruiz, 1996). An amino acid substitution E71D that is also shared by
American genotype strains has been implicated in controlling
virulence in mice (Bray et al., 1998). Furthermore, residues 381–384,
which facilitate the formation of a loop responsible for the serotype-
speciﬁc attachment of domain III to mosquito cells, were conserved
among all DENV-2 genotypes (Hung et al., 2004). Maximum-like-
lihood analysis indicated that amino acid positions L122K and D330G
were subject to weak (possibly immune) positive selective pressure
(Twiddy et al., 2002b). Among the DENV-2 genotypes, no nonsynon-
ymous mutations resulted in a net change in charge in the E protein,
an important observation since charged residues are important in the
interaction of antigenic sites with antibodies (Hasegawa et al., 1992;
Leitmeyer et al., 1999; Mandl et al., 1989). Many of the aforementioned
amino acid substitutions have been mapped to epitopes that are
recognized by elements of the cellular and humoral immune response,
and some may play a role in cellular tropism via modiﬁcation of the
receptor binding sites. Disrupting the immune response's ability to
detect and/or respond to DENV infection could have a dramatic effect
on pathogenesis and transmission. However additional studies in
nonhuman primates are needed to clearly deﬁne the roles of these
mutations in vivo. Moreover, mosquito infections with viruses
harboring these mutations have not been studied, effectively ignoring
a critical part of the transmission cycle in nature that is essential toNotes to Table 4:
Amino acid to the left represents amino acid on sylvatic viruses and to the right on the
endemic viruses. Arrows represent directionality of mutation.
a Indicates amino acid location from the start of the gene.
b E-Am: endemic American genotype; E-As: endemic Asian genotype; E: endemic
genotype.
c Indicates amino acid located within the S-adenosulmethionine-utilizing
methyltransferase (SAM) domain.
d Indicates amino acid located within the importin-β-binding domain and the
adjacent nuclear localization sequence (NLS) domain.
e Indicates amino acid located within the RNA-dependent RNA polymerase (RdRp)
domain.
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of sylvatic infectious clones utilizing reverse genetics may allow the
interpretation of the functional importance of these mutations in cell
tropism differences in sylvatic and endemic dengue viruses.
Nonstructural genes
Several nonsynonymous mutations were present throughout the
nonstructural protein genes. In NS1, a 46 kDa dimeric N-glycosylated
glycosyl-phosphatidylinositol (GPI) anchored protein that exists in
both intra- and extracellular forms (Jacobs et al., 2000; Winkler et al.,
1989), 26 endemic-speciﬁc nonsynonymous mutations were present.
Of these, seven (P73S, A99V, R170K, M/T177A, I242V, Y256N and
M347S) were shared among American genotypes, whereas 2 (R112K
and M/T177V) were shared among all Asian genotypes (Table 4).
However, the 12 cysteine residues that form disulﬁde bonds, as well as
the two N-linked glycosylation sites (N131 and N218) were fully
conserved.
In the NS2A, a 22 kDa protein involved in the coordination of
change between RNA packaging and replication (Khromykh et al.,
2001b) and possibly antagonism of interferon (IFN) (Jones et al., 2005;
Munoz-Jordan et al., 2003), 34 endemic-speciﬁc nonsynonymous
mutations were present, of which two pairs (I12V and N115V) and
(N115T and V120I), were shared only among Asian and American
genotypes respectively (Table 4). The lysine residue at position 190, an
important determinant for infectious ﬂavivirus production, was fully
conserved (Kummerer and Rice, 2002). In NS2B, a membrane-
associated 14 kDa protein that serves as a cofactor in the structural
activation of the DENV serine protease of NS3 (Erbel et al., 2006;
Leung et al., 2001), 6 endemic-speciﬁc nonsynonymous mutations
were present of which two (A57T and E62D) were shared American
genotype strains (Table 4). One of these mutations (V77I) is located
within a 12-amino acid hydrophobic region (70GSSPILSITISE81),
Φx3Φ, that associates directly with NS3 and results in reduced
autoproteolytic efﬁciency (Brinkworth et al., 1999; Niyomrattanakit et
al., 2004).
NS3, a 70 kDa multifunctional protein with a series of enzyme
activities such as trypsin-like serine protease, helicase, and RNA
triphosphatase (RTPase) (Gorbalenya et al., 1989; Li et al., 1999)
involved in the processing of the polyprotein and RNA replication, had
29 endemic-speciﬁc, nonsynonymous mutations. Four (K117R, A367T,
K466R and I568T) of these mutations were shared among the
American genotype strains, whereas 3 (I273V, R381K and R569K/Q)
were conﬁned to the Asian genotype (Table 4). The mutation at amino
acid position 186 (K186R) is located within a stretch of basic residues
(184RKRR187) that is essential for the RTPase activity of NS3 (Li et al.,
1999).
NS4A and NS4B, small hydrophobic proteins of 16 and 27 kDa,
respectively, with the latter functioning as an interferon (IFN)-
signaling inhibitor (Jones et al., 2005; Munoz-Jordan et al., 2003),
showed 10 and 8 nonsynonymous mutations respectively. In the
NS4A, two (R39K and V138I) mutations shared among the American
genotype strains, whereas in the NS4B, two pairs (G17H, I201V) and
(G17S, S245N) were shared among the American and Asian genotype
strains, respectively (Table 4). None of the NS4B mutations occured at
the positively selected sites identiﬁed in a recent study of sylvatic
DENV-2 evolution (Vasilakis et al., 2007a). However, the G17H/S
mutation and 10 out of 13 positively selected sites identiﬁed in our
previous study (Vasilakis et al., 2007a) fell within a region previously
identiﬁed as critical for IFN suppression (Munoz-Jordan et al., 2005).
NS5 is a large multifunctional, well-conserved protein of 103 kDa
with RNA cap-processing, RNA-dependent RNA polymerase (Ack-
ermann and Padmanabhan, 2001; Egloff et al., 2002), interleukin-8
(IL-8) (Medin et al., 2005) induction and nuclear localization (Pryor
et al., 2007; Uchil et al., 2006) activities. It exhibited 56 nonsynon-
ymous mutations, of which 10 and 12 were shared among theAmerican and Asian genotype strains, respectively (Table 4). Three of
the nonsynonymous mutations were located within the S-adenosyl-
methionine-utilizing methyltransferase (SAM) domain, 10 within the
importin-β-binding and nuclear localization sequence (NLS) domains
and 43 are within the RNA-dependent RNA polymerase (RdRp).
Interestingly, two of the 3 lysine residues (386K–387K) of the distal
cluster located within the NLS, and shown to be indispensable for
efﬁcient nuclear import of NS5 (Pryor et al., 2007), were substituted
with arginine (Table 4). Although these substitutions do not alter the
net charge of the cluster, previous studies have demonstrated that net
charge changes lead to virus attenuation (Hanley et al., 2002; Pryor et
al., 2007), probably due to IFN-antagonist properties of IL-8 produc-
tion (Khabar et al., 1997; Medin et al., 2005).
Although the functional importance of the nonstructural gene
mutations is not yet known, reverse genetic techniques may elucidate
their role, for example, in the emergence of endemic strains from
sylvatic progenitors. Of particular interest is the concentration of
putative positive selection in NS4B (Vasilakis et al., 2007a), a gene that
functions as an interferon (IFN)-signaling inhibitor, and their possible
role in distinguishing endemic and sylvatic DENV genotypes.
Phenotypic analyses
To assess replication in 2 primate cell lines as well as those of a
mosquito vector, replication kinetics were compared between
endemic and sylvatic DENV-2 genotypes. We included in our analysis
3 endemic strains (West African 1349 and TVP1915, and Southeast
Asian 16681) and 6 sylvatic strains, including some isolated from
humans in West Africa (Table 1). Titers of most viruses of both
endemic and sylvatic genotypes increased until day 4 p.i. in both Huh-
7 liver carcinoma cells and Vero (African green monkey kidney)
(Figs. 2A and B respectively) and day 5 p.i. in C6/36 mosquito cells
(Fig. 2C), after which titers plateaued or declined in all cell types. Huh-
7 cells exhibited pronounced cytopathic effects (CPE) by day 4 p.i.,
which became severe by 6 p.i. due to infection from all strains (data
not shown). Although Vero cells exhibited CPE due to infection from
all strains, it was less severe than the CPE observed in Huh-7 cells; C6/
36 cells exhibited no signs of CPE at all. Overall there was no
noticeable difference in CPE in response to sylvatic versus endemic
DENV infection in either Huh-7 or Vero cells.
Signiﬁcant inter-genotypic variation in mean virus output was
observed among strains of both endemic and sylvatic DENV-2
genotypes in all cell types (Figs. 2A–C). In Vero cells, repeated
measure ANOVA revealed that both isolate (F0.05, 8, 32=554.0,
Pb0.001) and sampling day (F0.05, 4, 32=6,759.3, Pb0.001) affected
mean titers, and that there was a signiﬁcant interaction between the
two (F0.05, 32, 72=116.4, Pb0.001), indicating that the shape of the
replication curve differed among isolates. Moreover, the replication
kinetics of every isolate differed from every other in Vero cells
(Tukey–Kramer post-hoc test, Pb0.05) with only two exceptions:
sylvatic strains DakAr HD10674 and DakAr D75505 did not differ
signiﬁcantly nor did sylvatic strains DakAr A510 and P8-1407. In this
cell line, sampling days 5 and 6 were excluded from analysis because
titers declined after day 4. In Huh-7 cells, both isolate (F0.05, 8, 40=
750.7, Pb0.001) and sampling day (F0.05, 5, 40=3,3634.0, Pb0.001)
had a signiﬁcant impact on titer and there was a signiﬁcant
interaction between the two (F0.05, 40,90=33.3, Pb0.001). In this cell
line, sampling day 6 was excluded from analysis. Replication
dynamics of every isolate differed from every other in Huh-7 cells
with ﬁve exceptions: sylvatic strain DakAr HD10674 did not differ
from sylvatic strains IBH11208 or DakAr A510, sylvatic strain DakAr
A510 did not differ from endemic strain 1349 or sylvatic strain
IBH11208, and endemic strains 16681 and TVP1915 did not differ.
Finally in C6/36 cells both isolate (F0.05, 8, 48=433.6, Pb0.001) and
sampling day (F0.05, 6, 48=6,678.4, Pb0.001) had a signiﬁcant impact
on titer and there was a signiﬁcant interaction between the two
Fig. 2. Comparative growth curves of DENV-2 strains. (A–C) Virus output of sylvatic (West African DakAr A510, DakAr D75505, IBH11208, IBH11234, DakAr HD10674 and Asian P8-
1407) and select endemic (Asian 16681, andWest African 1349 and TVP-1915) DENV-2 genotypes was evaluated on vertebrate cells lines Vero and Huh-7, andmosquito C6/36 cell line
up to 6 days p.i. (A–C, respectively). (D–F) Comparison of mean virus output of endemic and sylvatic DENV-2 genotypes on vertebrate cells lines Vero and Huh-7, and mosquito C6/36
cell line up to 6 days p.i. andmosquito cell lines (D–F, respectively). Mean virus output for endemic and sylvatic genotypes are represented by square and triangle bars respectively. All
infections were initiated at an MOI of 0.01.
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pairwise comparisons were signiﬁcantly different; the exceptions
were endemic strain 1349 and sylvatic strains DakAr D75505 andDakAr HD10674, respectively, sylvatic strain P8-1407 and endemic
strain TVP 1915, and sylvatic strain DakAr A510 with both endemic
strains 16681 and TVP1915.
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and sylvatic strains in each of the three cell types are shown in
Figs. 2D–F. In Huh-7 cells, the endemic strains reached signiﬁcantly
higher maximum titers than the sylvatic strains (t=2.6, df=7, P=0.04)
and replication dynamics were signiﬁcantly different between the two
groups (F0.05, 1, 5=8.5, P=0.022). This signiﬁcant difference between
endemic and sylvatic DENV-2 strains in both rapidity of replication
and peak titer in Huh-7 cells in culture (Fig. 2A), differs from previous
ﬁndings in vivo SCID mice engrafted with Huh-7 cells (SCID-Huh-7
mice) (Vasilakis et al., 2007b). It may be inappropriate to compare the
two studies directly because different sets of isolates were used to
represent the sylvatic and endemic ecotypes. Of particular impor-
tance, isolates from the American genotype of endemic DENV-2 were
used in the in vivo study; to date several studies, including Vasilakis et
al. (2007b) have reported that the American DENV-2 genotype
achieves signiﬁcantly lower titers in a variety of mammalian and
mosquito models relative to the Asian I genotype (Armstrong and
Rico-Hesse, 2003; Cologna et al., 2005; Cologna and Rico-Hesse, 2003;
Vasilakis et al., 2007b). In Vero and C6/36 cells, neither maximum titer
nor replication dynamics differed between the two genotypes (PN0.20
for all comparisons). These data support the previous conclusion that
extant, sylvatic DENV strains could re-emerge into the human
population (Vasilakis et al., 2007b).
Conclusions
Our phylogenetic analyses based on complete genome sequences
demonstrate that sylvatic DENV-2 isolates are evolutionarily distinct
from endemic DENV-2 isolates, supporting previous classiﬁcation of
DENV-2 into two discrete ecotypes. Although our genetic analyses
revealed considerable differences at both the nucleotide and protein
levels, several key elements (i.e. NCR secondary structures, disulﬁde
bridges, glycosylation sites) were fully conserved.
Several studies have suggested the importance of the cyclization
sequences in the replication of ﬂaviviral genomes (Khromykh et al.,
2001a; Khromykh and Westaway, 1997; Men et al., 1996; You and
Padmanabhan, 1999). It is thought that both 5′- and 3′-NCR play an
indispensable role throughout viral infection; in early stages facilitat-
ing the initiation of negative-strand synthesis and translation,
whereas in late stage replication allowing for strand-switching thus
facilitating the synthesis of plus-strand progeny RNAs and possibly
their packaging in progeny virus particles. Thus, nucleotide changes in
the 5′- and/or 3′-NCRs, as well as in the ORF, could alter the virus
phenotype and virulence (Hanley et al., 2004; Romero et al., 2006;
Sirigulpanit et al., 2007; Tajima et al., 2007; Whitehead et al., 2007).
Furthermore, computer-generated (Mathews et al., 1999; Zuker, 2003)
secondary structure predictions predict the involvement of these cis
interactions in either the 5′- or 3′-NCRs. Such structures may also
interact in trans, leading to the formation of double stranded
panhandle structures that share similar shape and thermal energy
(Markoff, 2003). Overall, in our analyses no differences of obvious
importance in the 5′- and/or 3′-NCR were detected.
The roles of the amino acid substitutions revealed by our analyses
in the emergence of endemic viruses from sylvatic progenitors, as well
as on the transmissibility of sylvatic DENV-2 in the peridomestic
mosquito vectors Ae. aegypti and Ae. albopictus, are not known and
merit further study. Our replication analyses in mammalian and
mosquito cell lines of select endemic and sylvatic genotypes,
representing diverse localities throughout the tropics and neotropics,
demonstrated no signiﬁcant differences in peak virus outputs,
implying the potential of sylvatic emergence into the endemic
transmission cycle. Similarly, previous studies examining the ﬁtness
of the ancestral sylvatic DENV-2 compared to currently circulating
endemic/epidemic strains, using surrogates for human infection
(Vasilakis et al., 2007b) and experimental infections of vectors (Diallo
et al., 2008, 2005) (K. Hanley, N. Vasilakis unpublished data), suggestthat little or no adaptation was required for the initial emergence of
endemic DENV-2 strains. This implies that the sylvatic cycles in Asia
and West Africa will remain a potential source of re-emergence.
Although several promising DENV vaccines under development may
lead to the eradication of endemic DENV strains in the future
(Whitehead et al., 2007), the sylvatic strains are not amenable to
control and most likely remain a potential reservoir for re-emergence
of endemic strains. Nonetheless, human herd immunity from prior
exposure to endemic DENV strains as well as sterilizing immunity
generated by live attenuated vaccine candidates is capable of sylvatic
strain neutralization (Vasilakis et al., in press), indicating that
sustained vaccination could prevent re-emergence. The above-
described studies, albeit with imperfect models of human infection
and testing of limited DENV strains, demonstrate that these viruses
exhibit a high degree of phenotypic strain variation with substantial
phenotypic overlap between ecotypes.
Utilization of reverse genetics to engineer speciﬁc mutations
identiﬁed in this study into a sylvatic DENV-2 genome may provide
valuable insights into the role of particular genes or amino acids in the
emergence of endemic viruses from sylvatic progenitors. Although,
evaluation of every observedmutation by reverse geneticswould not be
realistic or feasible, generation and evaluation of mutant viruses based
on mutations located within ‘hot spots’ such as, in the NS4B, or E could
provide clues for the genetic etiology of DENV emergence, as well as
whether or not these mutations distinguish endemic and sylvatic DENV
phenotypes. Moreover, many ecological traits of sylvatic DENV, includ-
ing the identityof vertebrate hosts in themaintenance andampliﬁcation
of sylvatic DENV and the degree and mechanism of contact between
humans and the sylvatic DENV cycle, have received little attention for
the last few decades. Recent evidence demonstrated the ability of
sylvatic DENV-2 to cause limited spillover epidemics in urban settings in
West Africa (Vasilakis et al., 2008). Therefore comprehensive ecological
and epidemiological studies of sylvatic DENV in West Africa and
Southeast Asia, where these strains circulate in proximity to human
populations, are needed in order to evaluate the human infection
potential and disease burden. Such studieswill allow characterization of
thedisease causedby sylvaticDENVstrains andquantiﬁcation of viremia
titers to determine the potential for infected people to initiate interhu-
man transmission if suitable vectors are present. Ecologic studies should
also identify potential ‘bridge’ vectors that could introduce sylvatic
DENV strains into ahuman transmission cycle. Although a recent genetic
analysis of sylvatic DENV demonstrated that the rate of evolutionary
change and pattern of natural selection are similar to those of endemic
DENV (Vasilakis et al., 2007a), little is known about the processes that
shape DENV evolution in this sylvatic cycle. Understanding the genetic
relationshipsbetweenendemic and sylvatic genotypesmayenhanceour
understanding of dengue emergence, as well as allow us to explore the
biological properties of sylvatic genotypes.
Materials and methods
Viruses and sequencing
Mostly low passage DENV isolates (Table 1) were obtained from
the UTMB World Reference Center for Emerging Viruses and
Arboviruses and ampliﬁed once in vitro in C6/36 mosquito cells to
achieve sufﬁciently high titers. The reason for choosing a viral isolate
of deﬁned early passage history is mainly due to the error-prone
nature of RNA polymerases leading to rapidly accumulating mutations
due to selection for replication in cell cultures (Domingo and Holland,
1994; Drake and Holland, 1999; Duarte et al., 1994).
Genomic viral RNA (vRNA) was isolated with the Qiagen viral RNA
isolation kit (Qiagen, Valencia). The 5′- and 3′-terminus sequences of
the speciﬁc genomes were determined by their ligation and sequen-
cing as demonstrated by Mandl et al. (1991). Initial overlapping cDNA
fragments and amplicons of these viruses were generated using
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step reverse transcriptase polymerase chain reaction (RT-PCR) (Roche
Diagnostics, Indianapolis), in eight overlapping cDNA fragments
containing genome nucleotide regions 1–1396, 1333–2688, 2619–
4049, 3986–5358, 5305–6736, 6667–8041, 7990–9382, and 9310–
10723 (Kinney et al., 1997) (Supplemental Table 3). First strand
synthesis was performed at 50 °C for 30 min, whereas ampliﬁcation
underwent for a total of 35 cycles with annealing temperature set at
5 °C below the lowest melting temperature (Tm) of the used PCR
primer pairs and extension set at 1min per 500 nucleotides. Ampliﬁed
sequences were gel puriﬁed and automated sequencing with speciﬁc
sequencing primers for both strands provided consensus sequences.
Nucleotide sequence accession numbers
The GenBank accession numbers for the genome sequences of DENV
viruses used in the phylogenetic analyses are as follows: for DENV-2
strain 900663, accession number AB189122; TB16i, AY858036; BA05i,
AY858035; TSV01, AY037116; FJ11, AF359579; CH43, AF204178; NGC,
AF038403; CH44, AF204177; 16681, U87411; NH29, AF169678; TH36,
AF169679; NH81, AF169688; CUB205, AY702038; CUB115, AY702036;
CUB13, AY702034; 703, AF208496; DR59, AB122022; 64022, AF489932;
IQT2913, AF100468; 348600, AY702040; and N.1409, M20558. DENV-1
and -3 strains, accession numbers AF226686 and NC_001475 respec-
tively. The following DENV-2 genome sequences were determined in
this study: P8-1407, EF105379; PM33974, EF105378; 1349, EU56810;
IQT1950, EU56811; 1328, EU56812; DakAr 510, EF105381; DakAr A1247,
EF105383; DakAr 2039, EF105382; DakAr A2022, EF105386; DakAr
HD10674, EF105384; DakAr D20761, EF105385; DakAr 578, EF105380;
DakAr 141069, EF105389; DakAr141070, EF105390; DakAr D75505,
EF457904; IBH11208, EF105387; IBH11664, EF105388; and IBH11234,
EU003591. DENV-1 and -4 sylvatic strains P72-1244, and P75-215,
accessionnumbers EF457905andEF457906 respectively. TVP-1915 is an
endemic DENV-2 strain isolated fromAe. aegypti in 1986 in Burkina Faso
and its sequence is not available.
Phylogenetic analyses
The obtained full genome sequences and representative genome
sequences from the GenBank library were aligned using the ClustalW
multiple sequence alignment function of MacVector version 8.0
(Accelrys) with default gap penalties. Phylogenetic analyses of the
aligned genomic sequences were estimated withmaximum likelihood
and distance/neighbor joining using the PAUP⁎ program version 4.10
(D.L. Swofford, Illinois Natural History Survey, Champaign) under the
general time-reversible model of nucleotide substitution. The para-
meter values used for the substitution type, optimal base composition,
proportion of invariable sites, as well as the shape parameter of the Γ
distribution of rate variation among sites were estimated from the
data and are available upon request. We also utilized Bayesian analysis
(MrBayes v3.1.0) where 4 MCMC tree searches of one million
generations each were run simultaneously sampling 1 in 100 trees
and computing a 50%majority-rule consensus tree out of the last 9800
sampled trees. Although we observed identical strain topologies with
either method, minor differences were observed among the bootstrap
values and thus we present only Bayesian phylogenies. Homologous
genome sequences from DENV-1, -3, and -4 were used as outgroups to
root the DENV tree. Bootstrapping obtained by the Bayesian analysis
was used to place conﬁdence values on groupingwithin the consensus
tree (Felsenstein, 1985). Character evolutionwas traced usingMaclade
4.0 (Sinauer Associates, Sunderland, MA).
Viral kinetics
Comparative replication curves of select sylvatic (West African
DakAr D77505, DakAr HD10674, IBH11234, IBH11208, DakAr 510 andAsian P8-1407) and endemic (Asian 16681, West African 1349 and
TVP-1915) DENV-2 were generated in triplicate on simian kidney
(Vero), human liver (Huh-7) and mosquito epithelial (C6/36) cells.
Vero, Huh-7 and C6/36 cells, at 2.5×105, 2.5×105, and 5.0×105 cells
per well respectively (~80% conﬂuency), were plated in 12-well plates
and infected with a multiplicity of 0.01 focus forming units per cell
(ffu/cell), in triplicate. Three 12-well plates containing 80% conﬂuent
Vero, mosquito C6/36 or Huh-7 cell monolayers were also prepared
and cell number was accurately determined. Human hepatoma Huh-7
cells (clone JTC-39) were obtained from the Japanese Health Sciences
Foundation, Osaka. Viruses were diluted in minimal essential medium
(MEM) supplemented with 5% heat inactivated fetal bovine serum
(FBS), 2 mM L-Glutamine, 1% nonessential amino acids (NEAA), and
50 mg/ml penicillin/streptomycin (Invitrogen, Carlsbad), at an MOI of
0.01 ffu/cell are infected simultaneously in triplicate. Infected dishes
were incubated for one hour with periodic gentle rocking to facilitate
virus adsorption at 37 °C. Viral inocula were removed and cell
monolayers were washed thrice with PBS to remove un-adsorbed
virus. Two milliliters of complete cell media (MEM supplemented
with 5% heat inactivated FBS, 2 mM L-Glutamine, 1% nonessential
amino acids (NEAA), and 50 mg/ml penicillin/streptomycin) was then
added and dishes were incubated at 29 °C or 37 °C for the mosquito or
mammalian cell lines respectively. At various times (1, 2, 3, 4, 5 and
6 days) post infection, virus from individual wells were harvested, and
puriﬁed by low speed centrifugation. Virus samples representing the
various time points were assayed immediately in C6/36 cells to
determine virus titer by focus forming immunoassay (FFA). Virus yield
at each timepoint was recorded as ffu/cell, represented as the ratio of
the total amount of virus present in the sample by the number of cells
originally infected.
Focus forming assays and immunostaining
Ten-fold serial dilutions of virus in minimal essential medium
(MEM) supplemented with 2% heat inactivated FBS and antibiotics
(Invitrogen, Carlsbad), were added to conﬂuent C6/36 cell monolayers
attached to 12-well Costar plates, and incubated for one hour with
periodic gentle rocking to facilitate virus adsorption at 37 °C.
Subsequent to hour-long incubation wells were overlayed with 1 ml
solution of 0.8% methylcellulose (Sigma-Aldrich, St. Louis) diluted in
warm Optimem (Invitrogen, Carlsbad) supplemented with 2% heat
inactivated FBS, antibiotics and 1% (w/v) L-glutamine and incubated
undisturbed for 4 days at 28 °C. Methylcellulose overlay was aspirated
and cell monolayer rinsed once with phosphate buffered saline (PBS),
pH 7.4 (Invitrogen, Carlsbad) followed by ﬁxation with a mixture of
ice-cold acetone and methanol (1:1) solution and allowed to incubate
for 30 min at room temperature (RT). Fixation solution was aspirated
and plates were allowed to air dry. Plates werewashed thrice with PBS
supplemented with 3% FBS, followed by hour-long incubation with a
dengue-speciﬁc mouse ascitic ﬂuid. Plates were washed thrice
followed by hour-long incubation with a secondary antibody
conjugated to horseradish peroxidase (HRP) (KPL, Gaithersburg).
Detection proceeded with the addition of aminoethylcarbazole
(AEC) substrate (ENZO Diagnostics, Farmingdale) prepared according
to vendor instructions. Antigen stained cells were counted against a
white background and viral titers were recorded as the reciprocal of
the highest dilution where adequate plaques (greater than 20 but
lower than 90) and expressed as focus forming units per ml (FFU/ml).
Statistical analyses
The replication dynamics of each of the 9 isolates was compared
using a repeated-measures ANOVA on the triplicate titer values of
each isolate at each timepoint, followed by a Tukey–Kramer post-hoc
test to compare individual pairs of isolates. Similarly, the replication
curve of endemic and sylvatic isolates was compared using a
306 N. Vasilakis et al. / Virology 377 (2008) 296–307repeated-measures ANOVA of the average titer value for each of the 6
sylvatic and 3 endemic isolates at each timepoint. Maximum titer
values of endemic and sylvatic isolates were compared using a
student's t-test. All analyses were conducted using Statview software
(SAS Institutes, Inc., Cary, NC).
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